Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Martin Berghoff, Anne Schänzer, Gerhard C. Hildebrandt, Benjamin Dassinger, Gothje Klappstein, Manfred Kaps, Elke R. Gizewski, Till Acker & Astrid Grams. (2013) Development of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma 13 years after treatment with cladribine. Leukemia & Lymphoma 54:6, pages 1340-1342.
Read now
Read now
Articles from other publishers (7)
Yawen Wang, Jiadai Xu, Jing Li, Zheng Wei, Miaojie Shi, Rong Tao, Bobin Chen, Yuyang Tian, Wenhao Zhang, Yan Ma, Lihua Sun, Yunhua Hou, Qilin Zhan, Jigang Wang, Hongwei Xue & Peng Liu. (2022) Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study. Annals of Hematology 101:10, pages 2139-2148.
Crossref
Crossref
Jenny-Lee Panayides, Véronique Mathieu, Laetitia Moreno Y. Banuls, Helen Apostolellis, Nurit Dahan-Farkas, Hajierah Davids, Leonie Harmse, M.E. Christine Rey, Ivan R. Green, Stephen C. Pelly, Robert Kiss, Alexander Kornienko & Willem A.L. van Otterlo. (2016) Synthesis and in vitro growth inhibitory activity of novel silyl- and trityl-modified nucleosides. Bioorganic & Medicinal Chemistry 24:12, pages 2716-2724.
Crossref
Crossref
Zainul Hasanali, Kamal Sharma & Elliot Epner. (2012) Flipping the cyclin D1 switch in mantle cell lymphoma. Best Practice & Research Clinical Haematology 25:2, pages 143-152.
Crossref
Crossref
Darren S. Sigal, Heather J. Miller, Ethan D. Schram & Alan Saven. (2010) Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood 116:16, pages 2884-2896.
Crossref
Crossref
S. Schmidt. (2010) Cladribin-Tabletten bei schubförmiger Multipler SkleroseOral cladribine for relapsing-remitting multiple sclerosis. Der Nervenarzt 81:10, pages 1231-1241.
Crossref
Crossref
Enrico Orciuolo, Gabriele Buda, Elisabetta Sordi, Claudia Baraté, Sara Galimberti, Eugenio Ciancia & Mario Petrini. (2010) 2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma. Leukemia Research 34:2, pages 184-189.
Crossref
Crossref
Kensei Tobinai, Takashi Watanabe, Kazuki Tanimoto, Dai Maruyama, Masanobu Nakata, Kuniaki Itoh, Yasuo Morishima, Michinori Ogura, Noriko Usui, Masaharu Kasai, Takashi Terauchi, Shigeru Nawano, Masaki Matsusako, Yoshihiro Matsuno, Shigeo Nakamura, Shigeo Mori & Yasuo Ohashi. (2009) Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. Cancer Science 100:7, pages 1344-1350.
Crossref
Crossref